دورية أكاديمية

Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations.

التفاصيل البيبلوغرافية
العنوان: Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations.
المؤلفون: Le LK; Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia., Esturas AC; Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia., Mihalopoulos C; Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia., Chiotelis O; Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia., Bucholc J; Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia., Chatterton ML; Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia., Engel L; Deakin University, Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Geelong, Australia.
المصدر: PLoS medicine [PLoS Med] 2021 May 11; Vol. 18 (5), pp. e1003606. Date of Electronic Publication: 2021 May 11 (Print Publication: 2021).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science, [2004]-
مواضيع طبية MeSH: Cost-Benefit Analysis/*statistics & numerical data , Health Promotion/*economics , Mental Disorders/*economics , Mental Health/*economics, Health Promotion/statistics & numerical data ; Humans ; Mental Disorders/therapy
مستخلص: Background: The prevention of mental disorders and promotion of mental health and well-being are growing fields. Whether mental health promotion and prevention interventions provide value for money in children, adolescents, adults, and older adults is unclear. The aim of the current study is to update 2 existing reviews of cost-effectiveness studies in this field in order to determine whether such interventions are cost-effective.
Methods and Findings: Electronic databases (including MEDLINE, PsycINFO, CINAHL, and EconLit through EBSCO and Embase) were searched for published cost-effectiveness studies of prevention of mental disorders and promotion of mental health and well-being from 2008 to 2020. The quality of studies was assessed using the Quality of Health Economic Studies Instrument (QHES). The protocol was registered with PROSPERO (# CRD42019127778). The primary outcomes were incremental cost-effectiveness ratio (ICER) or return on investment (ROI) ratio across all studies. A total of 65 studies met the inclusion criteria of a full economic evaluation, of which, 23 targeted children and adolescents, 35 targeted adults, while the remaining targeted older adults. A large number of studies focused on prevention of depression and/or anxiety disorders, followed by promotion of mental health and well-being and other mental disorders. Although there was high heterogeneity in terms of the design among included economic evaluations, most studies consistently found that interventions for mental health prevention and promotion were cost-effective or cost saving. The review found that targeted prevention was likely to be cost-effective compared to universal prevention. Screening plus psychological interventions (e.g., cognitive behavioural therapy [CBT]) at school were the most cost-effective interventions for prevention of mental disorders in children and adolescents, while parenting interventions and workplace interventions had good evidence in mental health promotion. There is inconclusive evidence for preventive interventions for mental disorders or mental health promotion in older adults. While studies were of general high quality, there was limited evidence available from low- and middle-income countries. The review was limited to studies where mental health was the primary outcome and may have missed general health promoting strategies that could also prevent mental disorder or promote mental health. Some ROI studies might not be included given that these studies are commonly published in grey literature rather than in the academic literature.
Conclusions: Our review found a significant growth of economic evaluations in prevention of mental disorders or promotion of mental health and well-being over the last 10 years. Although several interventions for mental health prevention and promotion provide good value for money, the varied quality as well as methodologies used in economic evaluations limit the generalisability of conclusions about cost-effectiveness. However, the finding that the majority of studies especially in children, adolescents, and adults demonstrated good value for money is promising. Research on cost-effectiveness in low-middle income settings is required.
Trial Registration: PROSPERO registration number: CRD42019127778.
Competing Interests: MLC has received Grant/research support from the National Health and Medical Research Council (NHMRC), Deakin University School of Health and Social Development, Deakin Health Economics, Institute for Health Transformation, icare Foundation, Medical Research Future Fund, Victorian medical research accelerator fund, beyondblue, Barwon Child, Youth & Family, and Medibank Health Research Fund. LK-DL has received Grant/research support from the National Health and Medical Research Council (NHMRC), Deakin University School of Health and Social Development, Deakin Health Economics, Deakin University. Other authors have declared that no competing interests exist.
References: Prev Sci. 2015 May;16(4):586-96. (PMID: 25382415)
Arch Pediatr Adolesc Med. 2011 Aug;165(8):756-62. (PMID: 21810638)
Psychol Med. 2015 May;45(7):1435-46. (PMID: 25330734)
J Anxiety Disord. 2020 Mar;70:102191. (PMID: 32014832)
J Epidemiol Community Health. 2012 Aug;66(8):745-53. (PMID: 22577180)
Int J Eat Disord. 2017 Jul;50(7):834-841. (PMID: 28323355)
BMC Public Health. 2008 Jan 22;8:20. (PMID: 18211677)
BMJ Open. 2016 Nov 18;6(11):e012086. (PMID: 27864246)
Am J Perinatol. 2013 Sep;30(8):631-42. (PMID: 23283805)
J Telemed Telecare. 2013 Jul;19(5):273-81. (PMID: 24163237)
J Manag Care Pharm. 2003 Jan-Feb;9(1):53-61. (PMID: 14613362)
J Epidemiol Community Health. 2012 Sep;66(9):782-90. (PMID: 21636614)
Psychiatr Serv. 2019 Apr 1;70(4):279-286. (PMID: 30929618)
Health Econ. 2019 Aug;28(8):1052-1063. (PMID: 31173431)
J Affect Disord. 2020 Dec 1;277:789-799. (PMID: 33065819)
Psychiatr Serv. 2019 Dec 1;70(12):1082-1087. (PMID: 31451063)
Soc Sci Med. 2019 Jan;220:353-361. (PMID: 30513485)
J Med Internet Res. 2013 Jan 23;15(1):e18. (PMID: 23343481)
Schizophr Bull. 2017 Mar 1;43(2):365-374. (PMID: 27306315)
Appl Health Econ Health Policy. 2020 Apr;18(2):189-201. (PMID: 31535350)
BMC Med. 2018 Feb 23;16(1):28. (PMID: 29471877)
Aust N Z J Psychiatry. 2018 Apr;52(4):328-338. (PMID: 29113456)
Appl Health Econ Health Policy. 2015 Oct;13(5):525-42. (PMID: 25972235)
J Occup Environ Med. 2014 May;56(5):554-60. (PMID: 24806569)
PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072)
Pediatrics. 2012 Mar;129(3):e723-30. (PMID: 22312000)
Psychol Med. 2014 May;44(7):1381-90. (PMID: 23947797)
J Ment Health Policy Econ. 2015 Sep;18(3):147-55. (PMID: 26474050)
Health Technol Assess. 2013 Oct;17(47):vii-xvii, 1-109. (PMID: 24172024)
Soc Psychiatry Psychiatr Epidemiol. 2020 Jul;55(7):823-836. (PMID: 31119308)
Epidemiol Psychiatr Sci. 2017 Oct;26(5):545-564. (PMID: 27509769)
Eur Child Adolesc Psychiatry. 2018 Oct;27(10):1295-1304. (PMID: 29442231)
Health Econ. 2001 Mar;10(2):179-84. (PMID: 11252048)
J Child Psychol Psychiatry. 2015 Sep;56(9):1026-33. (PMID: 26111550)
PLoS One. 2018 Jan 4;13(1):e0190554. (PMID: 29300754)
Crisis. 2013;34(2):98-106. (PMID: 23261913)
J Popul Ther Clin Pharmacol. 2013;20(2):e193-200. (PMID: 23880478)
Prev Med. 2016 Jun;87:70-80. (PMID: 26896634)
Early Interv Psychiatry. 2015 Apr;9(2):85-92. (PMID: 24962626)
Ind Health. 2013;51(6):627-33. (PMID: 24077445)
BMJ. 2013 Oct 25;347:f6342. (PMID: 24162943)
Eat Disord. 2017 May-Jun;25(3):263-272. (PMID: 28287919)
J Med Internet Res. 2017 Jan 04;19(1):e5. (PMID: 28052841)
Adm Policy Ment Health. 2020 Mar;47(2):300-315. (PMID: 31630323)
Aust Prescr. 2017 Apr;40(2):76-78. (PMID: 28507401)
BMC Psychiatry. 2018 Aug 23;18(1):265. (PMID: 30139332)
Trop Med Int Health. 2020 Oct;25(10):1205-1213. (PMID: 32687625)
Accid Anal Prev. 2007 May;39(3):565-73. (PMID: 17125723)
Psychiatr Serv. 2011 Dec;62(12):1416-8. (PMID: 22193786)
PLoS One. 2017 Aug 31;12(8):e0184210. (PMID: 28859154)
Lancet. 2018 Nov 10;392(10159):1789-1858. (PMID: 30496104)
J Adolesc. 2015 Dec;45:127-37. (PMID: 26433734)
Cost Eff Resour Alloc. 2009 Apr 24;7:8. (PMID: 19393084)
J Public Health (Oxf). 2018 Sep 1;40(3):557-566. (PMID: 28977629)
Am J Geriatr Psychiatry. 2014 Mar;22(3):253-62. (PMID: 23759290)
Int J Geriatr Psychiatry. 2014 Feb;29(2):182-90. (PMID: 23765874)
Trials. 2013 Sep 22;14:305. (PMID: 24053631)
Aust N Z J Psychiatry. 2011 Jan;45(1):36-44. (PMID: 21073354)
J Affect Disord. 2011 Feb;128(3):211-9. (PMID: 20696480)
Int J Eat Disord. 2017 Mar;50(3):250-258. (PMID: 28152203)
J Child Psychol Psychiatry. 2014 Dec;55(12):1390-7. (PMID: 24813670)
Med Decis Making. 2012 Sep-Oct;32(5):722-32. (PMID: 22990087)
Cost Eff Resour Alloc. 2013 Feb 20;11(1):4. (PMID: 23425608)
Health Technol Assess. 2013 May;17(18):1-281. (PMID: 23632142)
PLoS One. 2011;6(8):e22884. (PMID: 21853053)
Int J Nurs Stud. 2014 Oct;51(10):1321-31. (PMID: 24598375)
Eur J Neurol. 2012 Jan;19(1):155-62. (PMID: 22175760)
Br J Psychiatry. 2010 Apr;196(4):319-25. (PMID: 20357310)
Eur Child Adolesc Psychiatry. 2013 Oct;22(10):619-30. (PMID: 23539355)
Int J Evid Based Healthc. 2015 Sep;13(3):170-8. (PMID: 26288063)
BJPsych Open. 2019 Jan;5(1):e14. (PMID: 30762509)
Psychiatr Serv. 2018 Jan 1;69(1):23-31. (PMID: 28945181)
BMC Public Health. 2019 Oct 17;19(1):1309. (PMID: 31623597)
Expert Rev Pharmacoecon Outcomes Res. 2020 Jun;20(3):269-279. (PMID: 31195900)
Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275)
Suicide Life Threat Behav. 2018 Feb;48(1):3-11. (PMID: 27982449)
J Affect Disord. 2009 May;115(1-2):54-61. (PMID: 18817976)
Int J Occup Med Environ Health. 2015;28(5):891-900. (PMID: 26224500)
Appl Health Econ Health Policy. 2020 Apr;18(2):311-324. (PMID: 31410773)
Annu Rev Public Health. 2019 Apr 1;40:373-389. (PMID: 30601725)
World Psychiatry. 2015 Jun;14(2):231-3. (PMID: 26043341)
J Anxiety Disord. 2012 Mar;26(2):287-96. (PMID: 22245700)
Psychol Med. 2019 Jun;49(8):1324-1334. (PMID: 30157976)
Nutrients. 2020 Jul 31;12(8):. (PMID: 32752114)
تواريخ الأحداث: Date Created: 20210511 Date Completed: 20210825 Latest Revision: 20210825
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8148329
DOI: 10.1371/journal.pmed.1003606
PMID: 33974641
قاعدة البيانات: MEDLINE
الوصف
تدمد:1549-1676
DOI:10.1371/journal.pmed.1003606